You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Investigational Drug Information for Clenbuterol


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Clenbuterol?

Clenbuterol is an investigational drug.

There have been 11 clinical trials for Clenbuterol. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2023.

The most common disease conditions in clinical trials are Glycogen Storage Disease Type II, Cardiomyopathies, and Hypertrophy. The leading clinical trial sponsors are Dwight Koeberl, M.D., Ph.D., University of Copenhagen, and Maastricht University.

There are six hundred and twenty-eight US patents protecting this investigational drug and zero international patents.

Recent Clinical Trials for Clenbuterol
TitleSponsorPhase
A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular AtrophyMario Negri Institute for Pharmacological ResearchPhase 2
A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular AtrophyGianni SoraruPhase 2
Muscle Memory After Treatment With Anabolic Substance Clenbuterol and Resistance Training in HumansMorten Hostrup, PhDN/A

See all Clenbuterol clinical trials

Clinical Trial Summary for Clenbuterol

Top disease conditions for Clenbuterol
Top clinical trial sponsors for Clenbuterol

See all Clenbuterol clinical trials

US Patents for Clenbuterol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Clenbuterol ⤷  Sign Up SARMs and method of use thereof University of Tennessee Research Foundation (Knoxville, TN) ⤷  Sign Up
Clenbuterol ⤷  Sign Up Inhalable pharmaceutical compositions iCeutica Pty Ltd. (Iluka, WA, AU) ⤷  Sign Up
Clenbuterol ⤷  Sign Up Powder filling processes Adamis Pharmaceuticals Corporation (San Diego, CA) ⤷  Sign Up
Clenbuterol ⤷  Sign Up Compounds CHIESI FARMACEUTICI S.P.A. (Parma, IT) ⤷  Sign Up
Clenbuterol ⤷  Sign Up Compositions and methods for treating psychiatric disorders GOSFORTH CENTRE (HOLDINGS) PTY LTD. (Maroochydore, Queensland, AU) ⤷  Sign Up
Clenbuterol ⤷  Sign Up Silk powder compaction for production of constructs with high mechanical strength and stiffness TRUSTEES OF TUFTS COLLEGE (Medford, MA) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Clenbuterol

Drugname Country Document Number Estimated Expiration Related US Patent
Clenbuterol Argentina AR061980 2026-07-12 ⤷  Sign Up
Clenbuterol Argentina AR062536 2026-07-12 ⤷  Sign Up
Clenbuterol Austria AT344233 2020-08-24 ⤷  Sign Up
Clenbuterol Austria AT423092 2020-08-24 ⤷  Sign Up
Clenbuterol Austria AT430125 2020-08-24 ⤷  Sign Up
Clenbuterol Austria AT526959 2020-08-24 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.